Clinical Trial Update: TNFalfa Blocking Treatment of Spondylarthropathies [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating TNF-alpha blockade for spondyloarthropathies has completed, including ankylosing spondylitis and psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Spondyloarthropathies

Drugs mentioned

• TNF-alpha blocker

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Spondylarthropathies, Ankylosing Spondylitis | Phase 4 | Status: COMPLETED